US Stock MarketDetailed Quotes

ELVN Enliven Therapeutics

Watchlist
  • 21.680
  • +0.180+0.84%
Close Feb 14 16:00 ET
  • 21.680
  • 0.0000.00%
Post 16:01 ET
1.06BMarket Cap-12.02P/E (TTM)

About Enliven Therapeutics Company

Enliven Therapeutics, Inc. operates as a clinical stage precision oncology company. It is focused on the discovery and development of next-generation small molecule kinase inhibitors and advancing Enliven's pipeline of precision oncology product candidates. The company was founded by Sam S. Kintz, Joe P. Lyssikatos, and Anish Patel in June 2019 and is headquartered in Boulder, CO.

Company Profile

SymbolELVN
Company NameEnliven Therapeutics
Listing DateMar 12, 2020
Founded2019
CEOMr. Sam Kintz, M.B.A.
MarketNASDAQ
Employees46
Fiscal Year Ends12-31
Address6200 Lookout Road
CityBoulder
ProvinceColorado
CountryUnited States of America
Zip Code80301
Phone1-720-647-8519
Websitehttp://www.enliventherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Sam Kintz, M.B.A.
  • President, Chief Executive Officer and Director
  • 8.28M
  • Benjamin Hohl
  • Head of Corporate Development, Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Helen Collins, M.D.
  • Chief Medical Officer
  • 4.06M
  • Dr. Anish Patel, Pharm.D.
  • Chief Operating Officer
  • --
  • Dr. Richard Heyman, PhD
  • Chairman of the Board
  • 664.11K
  • Dr. Rahul D. Ballal, PhD
  • Director
  • 1.87M
  • Dr. Lori Anne Kunkel, M.D.
  • Director
  • --
  • Dr. Andrew Phillips, PhD
  • Independent Director
  • 542.95K
  • Jacob Bauer, M.B.A.
  • Independent Director
  • 551.21K
  • Dr. Mika Derynck, M.D.
  • Independent Director
  • 541.48K
  • Rishi Gupta, J.D.
  • Independent Director
  • 538.26K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
XINGANJIANG
873167
+30.00%
INNOVATIVE DATA
835305
+29.98%
CHENGUANG MEDICAL
430300
+29.96%
4
Hangzhou Gaoxin Materials Technology
300478
+20.04%
5
Beijing Philisense Technology
300287
+20.03%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!